Tagged Content
Tags > Medication Updates
Year: Medication:  Antipsychotics Belsomra Cymbalta Effexor Farxiga Geodon Hysingla ER Lunesta Methylphenidate Naloxone/Evzio Naltrexone Olanzapine/Zyprexa Opioids Tanzeum Targiniq ER Tramadol Treatment for Alcohol Use Disorder Vynase Ziprasidone Zolpidem Zyprexa General Resources:   DEA Pharmacists' Manual FDA Medication Updates NIMH Mental Health Medications Guide         2015 New Guidance on Medication-Assisted Treatment for Alcohol Use Disorder SAMHSA guide for expanding use of medication in clinical practice for the treatment of alcohol use disorder FDA expands uses of Vyvanse to treat binge-eating disorder Vynase (lisdexamfetamine dimesylate) is now approved to treat binge-eating disorder in adults. Extended-Release Injectable Naltrexone New SAMHSA guidance on the use of medication assisted treatment with extended-release injectable naltrexone for the treatment of opioid use disorder.       FDA reviews Zyprexa Relprevv The FDA study of two deaths associated with the injectable schizophrenia drug Zyprexa Relprevv were inconclusive.



View all tags
View RSS XML